Cargando…
Molecular Cytogenetic Characterization of Drug‐resistant Leukemia Cell Lines by Comparative Genomic Hybridization and Fluorescence in situ Hybridization
Resistance to chemotherapeutic drugs is one of the major difficulties encountered during cancer chemotherapy. To detect genomic aberrations underlying the acquired drug resistance, we examined three cultured human myelomonocytic leukemia cell sublines each resistant to adriamycin (ADR), 1‐β–1‐d‐arab...
Autores principales: | Shimizu, Hajime, Fukuda, Takeaki, Ghazizadeh, Mohammad, Nagashima, Mikio, Kawanami, Oichi, Suzuki, Toshimitsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927113/ https://www.ncbi.nlm.nih.gov/pubmed/12716468 http://dx.doi.org/10.1111/j.1349-7006.2002.tb01336.x |
Ejemplares similares
-
Diagnostic Utility of Multiprobe Fluorescence in situ Hybridization Assay for Detecting Cytogenetic Aberrations in Acute Leukemia
por: Kim, Bo-Ram, et al.
Publicado: (2014) -
Cytogenetic and interphase Fluorescence in Situ Hybridization studies in patients with multiple myeloma
por: Perumal, G, et al.
Publicado: (2014) -
Cytogenetic abnormality in patients with multiple myeloma analyzed by fluorescent in situ hybridization
por: Hu, Ying, et al.
Publicado: (2016) -
Clonal heterogeneity by fluorescence in situ hybridization in multiple myeloma: enhanced cytogenetic risk stratification
por: Abdel-Qader, Hadeel Yaseen, et al.
Publicado: (2022) -
Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma
por: Ha, Jihye, et al.
Publicado: (2022)